TDP-43 based biomarker development in amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis is a devastating neurodegenerative disease which is clinically and aetiologically heterogenous. However, TDP-43 neuropathology is a unifying hallmark found in 97% of ALS cases. Understanding the common pathological pathways downstream of TDP-43 dysregulation is essentia...
Κύριος συγγραφέας: | Feneberg, E |
---|---|
Άλλοι συγγραφείς: | Turner, M |
Μορφή: | Thesis |
Γλώσσα: | English |
Έκδοση: |
2019
|
Θέματα: |
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Heterogeneity of cortical pTDP-43 inclusion morphologies in amyotrophic lateral sclerosis
ανά: Rachel H. Tan, κ.ά.
Έκδοση: (2023-11-01) -
Advancements in TDP-43 research: Towards biomarkers and therapeutic targets for amyotrophic lateral sclerosis
ανά: Yuhan Wu, κ.ά.
Έκδοση: (2025-03-01) -
The role of TDP-43 protein in amyotrophic lateral sclerosis
ανά: Piotr Włodarczyk, κ.ά.
Έκδοση: (2022-12-01) -
Kinesitherapy in amyotrophic lateral sclerosis
ανά: Joanna Iłżecka
Έκδοση: (2017-12-01) -
Kinesitherapy in amyotrophic lateral sclerosis
ανά: Joanna Iłżecka
Έκδοση: (2017-12-01)